Discover
CTOR
Citius Oncology, Inc.
0.75
150 x 0.75
14 x 0.78
bid
ask
-
0.01
0.92%
undefined @ 04:00 PM
0.75 +0.00 (0.00%)
| Ytd | -24.70% | |
| 1y | -59.30% |
0.73
day range
0.79
0.49
52 week range
2.17
| Open | 0.79 | Prev Close | 0.76 | Low | 0.73 | High | 0.79 | Mkt Cap | 70.01M |
| Vol | 44.68K | Avg Vol | 66.20K | EPS | -0.47 | P/E | -1.60 | Forward P/E | N/A |
| Beta | 3.48 | Short Ratio | 0.37 | Inst. Own | 0.70% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | 0.69 | 200-d Avg | 0.99 | 1yr Est | 3.00 |
| Income Statement | |||
| Total Revenue | 1.67M | ||
| Revenues (USD) | 1.67M | ||
| Cost of Revenue | 328.88K | ||
| Gross Profit | 1.34M | ||
| Operating Expenses | 29.95M | ||
| Research and Development Expense | 1.08M | ||
| Selling, General and Administrative Expense | 23.63M | ||
| Operating Income | -28.61M | ||
| Interest Expense | 33.03K | ||
| Income Tax Expense | -231.21K | ||
| Net Income | -26.61M | ||
| Net Income Common Stock | -26.61M | ||
| Net Income Common Stock (USD) | -26.61M | ||
| Consolidated Income | -26.61M | ||
| Earnings per Basic Share | -0.27 | ||
| Earnings per Basic Share (USD) | -0.27 | ||
| Earnings per Diluted Share | -0.27 | ||
| Earning Before Interest & Taxes (EBIT) | -26.81M | ||
| Earning Before Interest & Taxes (USD) | -26.81M | ||
| Weighted Average Shares | 100.03M | ||
| Weighted Average Shares Diluted | 100.03M | ||
| Balance Sheet | |||
| Cash and Equivalents | 2.63M | ||
| Cash and Equivalents (USD) | 2.63M | ||
| Trade and Non-Trade Receivables | 1.08M | ||
| Current Assets | 29.42M | ||
| Total Assets | 100.70M | ||
| Total Debt | 3.80M | ||
| Current Liabilities | 58.81M | ||
| Debt Non-Current | 3.80M | ||
| Total Liabilities | 65.43M | ||
| Accumulated Retained Earnings (Deficit) | -96.18M | ||
| Shareholders Equity | 35.27M | ||
| Shareholders Equity (USD) | 35.27M | ||
| Assets Non-Current | 71.28M | ||
| Total Debt (USD) | 3.80M | ||
| Inventory | 22.66M | ||
| Liabilities Non-Current | 6.62M | ||
| Trade and Non-Trade Payables | 34.75M | ||
| Tax Liabilities | 2.82M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | -231.20K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.66M | ||
| Capital Expenditure | -600.00K | ||
| Issuance (Purchase) of Equity Shares | -61.95K | ||
| Net Cash Flow from Investing | -600.00K | ||
| Net Cash Flow from Operations | -3.83M | ||
| Share Based Compensation | 3.53M | ||